We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Human Stem Cells Used to Generate Functional Kidney-Like Structures

By LabMedica International staff writers
Posted on 04 Dec 2013
A paper described the successful differentiation of human stem cells into functioning kidney-like structures.

The high incidence of kidney disease and the poor prognosis support the urgent need for the development of new therapeutic strategies.

Investigators at the Salk Institute for Biological Studies (La Jolla, CA, USA) described progress in the use of induced pluripotent stem cells (iPSCs) for kidney disease research in the November 17, 2013, online edition of the journal Nature Cell Biology.

They generated iPSCs from skin cells and then grew them in cultures laced with growth factors known to be linked to kidney development. More...
The generated cells demonstrated rapid and specific expression of renal progenitor markers after four days of exposure to defined media conditions. Further maturation into ureteric bud structures was accomplished by employing a three-dimensional culture system in which the differentiated human cells assembled and integrated alongside mouse cells for the formation of chimeric ureteric buds. The ureteric bud is a protrusion from the mesonephric duct that appears during the development of the urinary and reproductive organs and eventually develops into the adult kidney.

“Attempts to differentiate human stem cells into renal cells have had limited success,” said senior author Dr. Juan Carlos Izpisua Belmonte, professor in the gene expression laboratory at the Salk Institute for Biological Studies. “We have developed a simple and efficient method that allows for the differentiation of human stem cells into well-organized three-D structures of the ureteric bud (UB), which later develops into the collecting duct system. Our results provide a new platform for the study of kidney diseases and lineage commitment, and open new avenues for the future application of regenerative strategies in the clinic.”

Related Links:

Salk Institute for Biological Studies



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.